Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Objectives: Minimally invasive extracorporeal CO2 removal is an accepted supportive treatment in chronic obstructive pulmonary disease patients. Conversely, the potential of such technique in treating acute respiratory distress syndrome patients remains to be investigated. The aim of this study was: 1) to quantify membrane lung CO2 removal (Vco 2ML) under different conditions and 2) to quantify the natural lung CO2 removal (Vco 2NL) and to what extent mechanical ventilation can be reduced while maintaining total expired CO2 (Vco 2tot = Vco 2ML + Vco 2NL) and arterial Pco 2 constant. Design: Experimental animal study. Setting: Department of Experimental Animal Medicine, University of Göttingen, Germany. Subjects: Eight healthy pigs (57.7 ± 5 kg). Interventions: The animals were sedated, ventilated, and connected to the artificial lung system (surface 1.8 m2, polymethylpentene membrane, filling volume 125 mL) through a 13F catheter. Vco 2ML was measured under different combinations of inflow Pco 2 (38.9 ± 3.3, 65 ± 5.7, and 89.9 ± 12.9 mm Hg), extracorporeal blood flow (100, 200, 300, and 400 mL/min), and gas flow (4, 6, and 12 L/min). At each setting, we measured Vco 2ML, Vco 2NL, lung mechanics, and blood gases. Measurements and Main Results: Vco 2ML increased linearly with extracorporeal blood flow and inflow Pco 2 but was not affected by gas flow. The outflow Pco 2 was similar regardless of inflow Pco 2 and extracorporeal blood flow, suggesting that Vco 2ML was maximally exploited in each experimental condition. Mechanical ventilation could be reduced by up to 80–90% while maintaining a constant Paco 2. Conclusions: Minimally invasive extracorporeal CO2 removal removes a relevant amount of CO2 thus allowing mechanical ventilation to be significantly reduced depending on extracorporeal blood flow and inflow Pco 2. Extracorporeal CO2 removal may provide the physiologic prerequisites for controlling ventilator-induced lung injury.
Objectives: Minimally invasive extracorporeal CO2 removal is an accepted supportive treatment in chronic obstructive pulmonary disease patients. Conversely, the potential of such technique in treating acute respiratory distress syndrome patients remains to be investigated. The aim of this study was: 1) to quantify membrane lung CO2 removal (Vco 2ML) under different conditions and 2) to quantify the natural lung CO2 removal (Vco 2NL) and to what extent mechanical ventilation can be reduced while maintaining total expired CO2 (Vco 2tot = Vco 2ML + Vco 2NL) and arterial Pco 2 constant. Design: Experimental animal study. Setting: Department of Experimental Animal Medicine, University of Göttingen, Germany. Subjects: Eight healthy pigs (57.7 ± 5 kg). Interventions: The animals were sedated, ventilated, and connected to the artificial lung system (surface 1.8 m2, polymethylpentene membrane, filling volume 125 mL) through a 13F catheter. Vco 2ML was measured under different combinations of inflow Pco 2 (38.9 ± 3.3, 65 ± 5.7, and 89.9 ± 12.9 mm Hg), extracorporeal blood flow (100, 200, 300, and 400 mL/min), and gas flow (4, 6, and 12 L/min). At each setting, we measured Vco 2ML, Vco 2NL, lung mechanics, and blood gases. Measurements and Main Results: Vco 2ML increased linearly with extracorporeal blood flow and inflow Pco 2 but was not affected by gas flow. The outflow Pco 2 was similar regardless of inflow Pco 2 and extracorporeal blood flow, suggesting that Vco 2ML was maximally exploited in each experimental condition. Mechanical ventilation could be reduced by up to 80–90% while maintaining a constant Paco 2. Conclusions: Minimally invasive extracorporeal CO2 removal removes a relevant amount of CO2 thus allowing mechanical ventilation to be significantly reduced depending on extracorporeal blood flow and inflow Pco 2. Extracorporeal CO2 removal may provide the physiologic prerequisites for controlling ventilator-induced lung injury.
Extracorporeal life support (ECLS) for severe respiratory failure has seen an exponential growth in recent years. Extracorporeal membrane oxygenation (ECMO) and extracorporeal CO2 removal (ECCO2R) represent two modalities that can provide full or partial support of the native lung function, when mechanical ventilation is either unable to achieve sufficient gas exchange to meet metabolic demands, or when its intensity is considered injurious. While the use of ECMO has defined indications in clinical practice, ECCO2R remains a promising technique, whose safety and efficacy are still being investigated. Understanding the physiological principles of gas exchange during respiratory ECLS and the interactions with native gas exchange and haemodynamics are essential for the safe applications of these techniques in clinical practice. In this review, we will present the physiological basis of gas exchange in ECMO and ECCO2R, and the implications of their interaction with native lung function. We will also discuss the rationale for their use in clinical practice, their current advances, and future directions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.